Search results for "metaanalysis"

showing 10 items of 150 documents

A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic

2021

© The Author(s), under exclusive licence to Springer Nature Limited 2021, corrected publication 2022

MaleSTRESSEmotionsPsychological interventionSocial Sciences[SHS.PSY]Humanities and Social Sciences/PsychologyREAPPRAISAL INTERVENTIONSBehavioral neuroscienceNEGATIVE AND POSITIVE EMOTIONSBehavioral Neuroscience0302 clinical medicineddc:150[STAT.ML]Statistics [stat]/Machine Learning [stat.ML]PandemicPsychologyANXIETYCovid-19 reappraisal emotionsR PACKAGE//purl.org/becyt/ford/5.1 [https]ComputingMilieux_MISCELLANEOUSRepurposingmedia_common//purl.org/becyt/ford/5 [https]05 social sciencesDIVERGENT ASSOCIATIONSPOSITIVE EMOTIONS3. Good health[SCCO.PSYC]Cognitive science/PsychologyMULTI-COUNTRY TESTadult; COVID-19; female; humans; male; emotional regulation; emotions/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingAnxietyFemaleCOGNITIVE REAPPRAISALPsychological resiliencemedicine.symptomPsychology[STAT.ME]Statistics [stat]/Methodology [stat.ME]Clinical psychologyAdultSocial Psychologymedia_common.quotation_subjectExperimental and Cognitive PsychologyArticle050105 experimental psychologyCognitive reappraisal03 medical and health sciencesSDG 3 - Good Health and Well-beingHuman behaviourmedicineHumans0501 psychology and cognitive sciencesMETAANALYSISBehaviour Change and Well-beingpandemicCOVID-19reappraisalRESILIENCENEGATIVE AFFECTMental healthEmotional RegulationREGULATION STRATEGIES030217 neurology & neurosurgeryNature Human Behaviour
researchProduct

Does Sleep Mediate the Association between School Pressure, Physical Activity, Screen Time, and Psychological Symptoms in Early Adolescents? A 12-Cou…

2019

This study examines the mediating role of sleep duration and sleep onset difficulties in the association of school pressure, physical activity, and screen time with psychological symptoms in early adolescents. Data were retrieved from 49,403 children (13.7 &plusmn

MaleSTRESSHealth Toxicology and MutagenesisPsychological interventionSocial Scienceslcsh:MedicinePoison controlCHILDRENSuicide prevention0302 clinical medicinenuoretmielenterveysSleep Initiation and Maintenance DisordersAcademic PerformanceMedicine and Health SciencesPrevalence030212 general & internal medicineadolescentsChildEUROPEAN ADOLESCENTSSchoolsAGE-OF-ONSETta3142EuropeDEPRESSIVE SYMPTOMSFemalemedicine.symptomSleep onsetBEHAVIORmental healthClinical psychologyAdolescentDISORDERSEXERCISEIrritabilityArticleuni (lepotila)Screen Time03 medical and health sciencesScreen timeSciences socialesInjury preventionmedicineHumansVALIDITYsleepExerciseMETAANALYSISbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMental healthSciences humainesmental health adolescents sleep AGE-OF-ONSET EUROPEAN ADOLESCENTS DEPRESSIVE SYMPTOMS CHILDREN STRESS METAANALYSIS DISORDERS EXERCISE VALIDITY BEHAVIORSelf Reportbusiness030217 neurology & neurosurgeryStress Psychological
researchProduct

Large-scale brain networks emerge from dynamic processing of musical timbre, key and rhythm

2012

We investigated the neural underpinnings of timbral, tonal, and rhythmic features of a naturalistic musical stimulus. Participants were scanned with functional Magnetic Resonance Imaging (fMRI) while listening to a stimulus with a rich musical structure, a modern tango. We correlated temporal evolutions of timbral, tonal, and rhythmic features of the stimulus, extracted using acoustic feature extraction procedures, with the fMRI time series. Results corroborate those obtained with controlled stimuli in previous studies and highlight additional areas recruited during musical feature processing. While timbral feature processing was associated with activations in cognitive areas of the cerebel…

MaleSpeech recognition0302 clinical medicineBASAL GANGLIAPREMOTORDefault mode networkMusical formBrain MappingTemporal evolutionmedicine.diagnostic_test05 social sciencesfMRIBrainREGIONSMagnetic Resonance ImaginghumanitiesNeurologyta6131SYNCHRONIZATIONAuditory PerceptionFemalePsychologypsychological phenomena and processesCognitive psychologyAuditory perceptionComputational feature extractionCognitive NeuroscienceFeature extractionMusic processingTOPOGRAPHYStimulus (physiology)ta3112behavioral disciplines and activities050105 experimental psychology03 medical and health sciencesYoung Adultotorhinolaryngologic diseasesmedicineEMOTIONHumans0501 psychology and cognitive sciencesTonalityMETAANALYSISPERCEPTIONNaturalistic stimulusNerve NetFunctional magnetic resonance imagingTimbre030217 neurology & neurosurgeryMusicAUDITORY-CORTEXNEUROIMAGE
researchProduct

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

2016

International audience; BACKGROUND:We investigated whether sirolimus-based immunosuppression improves outcomes in liver transplantation (LTx) candidates with hepatocellular carcinoma (HCC).METHODS:In a prospective-randomized open-label international trial, 525 LTx recipients with HCC initially receiving mammalian target of rapamycin inhibitor-free immunosuppression were randomized 4 to 6 weeks after transplantation into a group on mammalian target of rapamycin inhibitor-free immunosuppression (group A: 264 patients) or a group incorporating sirolimus (group B: 261). The primary endpoint was recurrence-free survival (RFS); intention-to-treat (ITT) analysis was conducted after 8 years. Overal…

MaleTime FactorsIntention to Treat Analysimedicine.medical_treatmentMedizinPROGRESSIONKaplan-Meier EstimateLiver transplantationGastroenterologyImmunosuppressive Agent0302 clinical medicineEVEROLIMUSRENAL-CELL CARCINOMARisk FactorsMedicine and Health SciencesClinical endpointAge FactorSirolimuProspective StudiesIMMUNOSUPPRESSIONTOR Serine-Threonine KinaseTOR Serine-Threonine KinasesHazard ratioLiver NeoplasmsAge FactorsImmunosuppressionMiddle AgedCANCER3. Good healthIntention to Treat AnalysisEuropeRAPAMYCIN INHIBITORSTreatment OutcomeTARGETLocalLiver Neoplasm030220 oncology & carcinogenesisCombinationDisease ProgressionSURVIVAL[SDV.IMM]Life Sciences [q-bio]/Immunology030211 gastroenterology & hepatologyDrug Therapy CombinationFemaleImmunosuppressive Agentsmedicine.drugHumanAdultmedicine.medical_specialtyCanadaCarcinoma HepatocellularTime Factor[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/SurgeryRisk AssessmentDisease-Free Survival03 medical and health sciencesYoung AdultDrug TherapyInternal medicinemedicineHumansAdult; Age Factors; Aged; Australia; Canada; Carcinoma Hepatocellular; Disease Progression; Disease-Free Survival; Drug Therapy Combination; Europe; Female; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence Local; Prospective Studies; Risk Assessment; Risk Factors; Sirolimus; TOR Serine-Threonine Kinases; Time Factors; Treatment Outcome; Young Adult; Liver Transplantation; TransplantationRECURRENCEMETAANALYSISAgedSirolimusTransplantationEverolimusIntention-to-treat analysisbusiness.industryRisk FactorCarcinomaAustraliaHepatocellular3126 Surgery anesthesiology intensive care radiologySurgeryLiver TransplantationTransplantationProspective StudieNeoplasm RecurrenceSirolimusNeoplasm Recurrence Localbusiness
researchProduct

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.

2016

OBJECTIVE To assess the association between early and prolonged beta blocker treatment and mortality after acute myocardial infarction. DESIGN Multicentre prospective cohort study. SETTING Nationwide French registry of Acute ST- and non-STelevation Myocardial Infarction (FAST-MI) (at 223 centres) at the end of 2005. PARTICIPANTS 2679 consecutive patients with acute myocardial infarction and without heart failure or left ventricular dysfunction. MAIN OUTCOME MEASURES Mortality was assessed at 30 days in relation to early use of beta blockers (<= 48 hours of admission), at one year in relation to discharge prescription, and at five years in relation to one year use. RESULTS beta blockers were…

MaleTime FactorsMyocardial Infarction030204 cardiovascular system & hematologyCorrectionsCohort Studies0302 clinical medicineMedicine030212 general & internal medicineMyocardial infarctionProspective StudiesProspective cohort studyHazard ratioGeneral MedicineMiddle AgedMetaanalysisPatient Discharge3. Good healthManagementImpactAcute DiseaseCardiologyFemaleLife Sciences & Biomedicinemedicine.medical_specialtyRegistrySt-Segment-Elevationmedicine.drug_classAdrenergic beta-AntagonistsGuidelines03 medical and health sciencesMedicine General & InternalFast-MiInternal medicineGeneral & Internal Medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyClinical-OutcomesHumansBeta blockerSurvival analysisAgedProportional Hazards ModelsHeart FailureScience & Technologybusiness.industryProportional hazards modelResearchCoronary Care Unitsmedicine.diseaseSurvival AnalysisDiscontinuationLogistic ModelsAdherenceHeart failureTherapybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyBMJ (Clinical research ed.)
researchProduct

Relations between subdomains of physical activity, sedentary lifestyle, and quality of life in young adult men

2018

Purpose To assess the relationship between physical activity (PA) in work, transport, domestic and leisure-time domains (with sitting time included) and health-related quality of life (HRQoL) among young adult men. Methods The long version of IPAQ and SF-36 Health Survey were used to assess PA and HRQoL, respectively, in 1425 voluntary 20 to 40 year old Finnish male participants. Participants were divided into tertiles (MET-h/week): Lowest tertile ( 100 MET-h/week). Results The IPAQ domain leisure-time PA predicted positively the Physical Component Summary (PCS) (β=0.11, 95% CI: 0.06 to 0.16) and Mental Component Summary (MCS) (β=0.11, 95% CI: 0.05 to 0.16) dimensions. Occupational PA predi…

MaleTime Factorselämänlaatu0302 clinical medicineQuality of lifeSITTING TIMEOrthopedics and Sports Medicine030212 general & internal medicineYoung adultFinlandPOPULATIONeducation.field_of_studyexercisepublic healthta3141ta3142ASSOCIATIONSitting timehumanitiesLinear relationshipMETmiehetHEALTHfyysinen aktiivisuusAdultyoung adultsCOUNTRIESmedicine.medical_specialtySF-36PopulationPhysical activitymenPhysical Therapy Sports Therapy and Rehabilitationphysical activeness03 medical and health sciencesYoung AdultSF-36medicineHumansVALIDITYeducationMETAANALYSISSedentary lifestyle030203 arthritis & rheumatologynuoret aikuisetbusiness.industryMORTALITYquestionnaires3126 Surgery anesthesiology intensive care radiologyHealth SurveysACTIVITY QUESTIONNAIRE IPAQCross-Sectional Studiesquality of lifePhysical therapySedentary BehaviorbusinessDemography
researchProduct

Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome

2015

Purpose To report the incidence and characteristics of endophthalmitis after intravitreal injections of anti–vascular endothelial growth factor agents or corticosteroids and to describe the clinical and bacteriologic characteristics, management, and outcome of these eyes with acute endophthalmitis in France. Design Retrospective, nationwide multicenter case series. Methods From January 2, 2008 to June 30, 2013, a total of 316 576 intravitreal injections from 25 French ophthalmic centers were included. For each center, the number of intravitreal injections was determined using billing codes and the injection protocol was recorded. A registry and hospital records were reviewed to identify pat…

MaleVisual acuityfactor agentsVisual AcuityAngiogenesis InhibitorsEye Infections BacterialEndophthalmitisAntisepticRisk Factorscausative organismsrisk-factorsAged 80 and overEndophthalmitis[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyIncidence (epidemiology)IncidenceMiddle AgedAnti-Bacterial Agents[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansIntravitreal InjectionsFemaleFrancePresentation (obstetrics)medicine.symptommetaanalysisAdultmedicine.medical_specialtymacular degenerationmedicine.drug_classRetinal DiseasesmedicineHumansranibizumab[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansGlucocorticoidsAgedRetrospective Studiesocular surfaceBacteriabusiness.industryRetrospective cohort studyantibiotic-prophylaxisEye infectionmedicine.diseaseConfidence intervalSurgeryVitreous BodyOphthalmologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyoperating-roomendothelial growth-factor
researchProduct

Associations of the MCM6-rs3754686 proxy for milk intake in Mediterranean and American populations with cardiovascular biomarkers, disease and mortal…

2016

Controversy persists on the association between dairy products, especially milk, and cardiovascular diseases (CVD). Genetic proxies may improve dairy intake estimations, and clarify diet-disease relationships through Mendelian randomization. We meta-analytically (n T (nonpersistence>persistence), dairy intake, and CVD biomarkers in American (Hispanics, African-American and Whites) and Mediterranean populations. Moreover, we analyzed longitudinal associations with milk, CVD and mortality in PREDIMED), a randomized Mediterranean diet (MedDiet) intervention trial (n = 7185). The MCM6-rs3754686/MCM6-rs309180 (as proxy), LP-allele (T) was strongly associated with higher milk intake, but inconsis…

MalealelosMediterranean dietMETABOLIC RISK-FACTORShumanosSINGLE-NUCLEOTIDE POLYMORPHISMComponente 6 del complejo de mantenimiento de minicromosomasDisease030204 cardiovascular system & hematologyMediterraneanAssociationsDiet MediterraneanMediterranean populationMCM6-rs37546860302 clinical medicineMedicineDisease030212 general & internal medicinemediana edadDAIRY CONSUMPTION2. Zero hungerancianoeducation.field_of_studyBioquímica y tecnologíaMultidisciplinarydietaMediterranean RegionHàbits alimentarisMendelian Randomization AnalysisMiddle AgedLlet3. Good healthBiochemistry and technologyBODY-WEIGHTCardiovascular diseasesMilkAmerican populationCardiovascular DiseasesMeta-analysisMarcadors bioquímicsFOOD-FREQUENCY QUESTIONNAIREFemaleLlet -- Aspectes nutricionalsGenetic MarkersFood habitsPopulationenfermedades cardiovascularesUNITED-STATESSistema cardiovascular malaltiesBioquímica i biotecnologiaArticleDIETleche03 medical and health sciencesSex Factors:Ciencias de la Salud::Medicina preventiva [Materias Investigacion]Sistema cardiovascular -- Malalties -- Aspectes genèticsEnvironmental healthMendelian randomizationMortalitatSNPAnimalsHumansPUERTO-RICANMortalityeducationMilk intakeLACTASE-PERSISTENCE PHENOTYPEAllelescardiovascular biomarkersAgedbusiness.industryMalalties cardiovascularsCardiovascular biomarkersmarcadores genéticosMendelian Randomization AnalysisMinichromosome Maintenance Complex Component 6United StatesDietBiotechnologyCardiovascular diseases (CVD)Lactase persistence2045-2322animalesanálisis de la aleatorización mendelianaDOSE-RESPONSE METAANALYSIS:Ciencias de la Salud::Endocrinología [Materias Investigacion]business
researchProduct

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

2016

BACKGROUND The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious asthma-related events associated with LABAs. This study was designed to evaluate the risk of administering the LABA salmeterol in combination with an inhaled glucocorticoid, fluticasone propionate. METHODS In this multicenter, randomized, double-blind trial, adolescent and adult patients (age, ≥12 years) with persistent asthma were assigned to receive either fluticasone with salmeterol or fluticasone alone for 26 weeks. All the patients had a history of a severe asthma exacerbation in t…

Maleasthma ; serious events ; fluticasone ; salmeterol ; AUSTRIExacerbationIntention to Treat AnalysiINHALED CORTICOSTEROIDSSeverity of Illness Indexlaw.invention0302 clinical medicineRandomized controlled triallawimmune system diseasesÚs terapèuticBroncodilatadors030212 general & internal medicineChildFluticasoneRISKACTING BETA-AGONISTS; INHALED CORTICOSTEROIDS; RISK; EXACERBATIONS; METAANALYSIS; MORTALITY; SAFETY; DEATH; FDAMedicine (all)Hazard ratioDEATHGeneral MedicineBronchodilator agentsMiddle AgedFluticasone-Salmeterol Drug CombinationBronchodilator AgentsIntention to Treat AnalysisAnesthesiaSAFETYFemaleSalmeterolFDAmedicine.drugHumanAdultmedicine.medical_specialtyAdolescentSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionate03 medical and health sciencesDouble-Blind MethodInternal medicineAdministration InhalationmedicineHumansMETAANALYSISAsmaBronchodilator AgentAsthmaAgedProportional Hazards ModelsFluticasone-Salmeterol Drug Combinationbusiness.industryMORTALITYACTING BETA-AGONISTSTherapeutic usemedicine.diseaseAsthmarespiratory tract diseasesEXACERBATIONS030228 respiratory systemFluticasone Propionate Salmeterol Xinafoate Drug CombinationProportional Hazards ModelFluticasonebusiness
researchProduct

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

2019

The EUGEI project was supported by the grant agreement HEALTH-F2-2010-241909 from the European Community’s Seventh Framework Programme. The authors are grateful to the patients and their families for participating in the project. They also thank all research personnel involved in the GROUP project, in particular J. van Baaren, E. Veermans, G. Driessen, T. Driesen, E. van’t Hag and J. de Nijs. Bart PF Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation.

MalecannabisLogistic regression0302 clinical medicineLasso (statistics)Adverse Childhood ExperiencesStatisticsOdds RatioChild AbusePOLYGENIC RISKpsychosisChildPsychiatrySUMMER BIRTHFramingham Risk Score3. Good healthExposomePsychiatry and Mental healthmachine learningSchizophreniaArea Under CurveFemaleMarijuana UseSeasonsEnvironment And Schizophrenia—Feature Editor: Jim van OsLife Sciences & Biomedicineenvironmentpredictive modelingAdultExposomeDISORDERSrisk scoreYoung Adult03 medical and health sciencesPSYCHOSISmedicineJournal ArticleHumansHearing LossMETAANALYSISDEFICIT SCHIZOPHRENIAENVIRONMENTModels StatisticalScience & Technologychildhood traumaReceiver operating characteristicbusiness.industrySiblingsBullyingBayes TheoremChild Abuse SexualOdds ratiohearing impairmentmedicine.disease030227 psychiatryschizophreniaLogistic ModelsROC CurveSexual abuseCase-Control StudiesbusinessCHILDHOOD ADVERSITIES030217 neurology & neurosurgerywinter birth
researchProduct